Sleep Disorders Trial, Recruiting NCT06584513 Sponsor: Insel Gruppe AG, University Hospital Bern Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06584513
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 65 years old or older
  • You have been taking sleep medications (such as benzodiazepines or similar sleeping pills) at least 3 times a week on average over the past 3 months, based on what you or a family member/carer reports
  • You are taking these sleep medications specifically to help with sleep problems, based on what you or a family member/carer reports

Who may not be able to join:

  • You are currently taking sleep medications to help with alcohol withdrawal
  • You are taking sleep medications as part of treatment for addiction
  • You have a condition called REM Sleep Behaviour Disorder
  • You have an active diagnosis of certain serious sleep disorders (called non-REM parasomnias) that could put you or others at risk of harm, or that happen very often or cause significant social difficulties
  • You have epilepsy in any form, because reducing sleep medication could increase the risk of seizures
  • You currently have a severe anxiety disorder, such as obsessive compulsive disorder, social phobia, PTSD, or panic disorder
  • You currently have a diagnosis of a psychotic disorder, with or without medication
  • You currently have a diagnosis of severe depression, with or without significant anxiety
  • You currently have a diagnosis of bipolar disorder, with or without significant anxiety
  • You are currently having thoughts of suicide
  • You are already working with a doctor on a planned, supervised programme to reduce your sleep medications
  • You are expected to be admitted to palliative (end-of-life) care within 24 hours, or your life expectancy is estimated to be less than 12 months
  • You are unable to give your own informed consent due to reasons such as memory or thinking difficulties — unless a trusted representative can consent on your behalf, actively take part in the study, and you show no signs of disagreement with taking part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Insel Gruppe AG, University Hospital Bern
Registry
ClinicalTrials.gov
Start date
18 November 2024
Est. completion
1 February 2026

Where this trial is recruiting

🇧🇪 Belgium 🇬🇷 Greece 🇳🇴 Norway 🇵🇱 Poland 🇪🇸 Spain 🇨🇭 Switzerland

Primary endpoints

BSH discontinuation; Quality of sleep

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov